CompletedPhase 2
Does Tranexamic acid, a medicine used in treating and preventing bleeding problems, reduce the blood loos when it is injected directly into the hip joint after insertion of a total hip prosthesis
Key facts
- Who runs it
- Region Hovedstaden
- Where
- Denmark1 site in 1 countryChoose a country to see its sites
- Status
- Completed
- Phase
- Phase 2
- People taking part
- 100 people enrolled
- Started
- 18 Oct 2022
- Ended
- 20 Sept 2026
- Type of study
- Interventional
- Record updated
- 11 December 2025
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 19 criteriaShow less
Who can take part
- ≥ 18 years
- Undergoing surgery for unilateral total hip arthroplasty
- Able to give ones consent either verbally or written
Who cannot take part
- In treatment with the following anticoagulatia: ADP receptorinhibitors, vitamin-K antagonist(within 5-7 days before the operation). Factor Xa inhibitors, thrombine-inhibitors
- Disseminated intravascular coagulation (DIC) or active thromboembolic disease
- Active cancer disease
- Reduced kidney function (GFR <45 ml/hour)
- Operation performed in general anaesthesia
- Patients who are not able to speak and understand Danish
- Patients who refuse to receive blood products
- Present acute thromboembolic event (DVT, AMI, cerebral infarction, pulmonary embolism)
- Had one of the following type of trauma or surgeries in the affected hip: Hip fractures, periacetabulær osteotomy, femurosteotomy, trochanterostetomi
- Rheumatic arthritis
- Allergi to TXA
- Use of oral anticonceptiva
- Known with thrombophilia
- Participated in a clinical trial within the last 30 days
- Alcoholism and morphinism
- Females: menstruation within the last 12 months
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
In this RCT-study we investigate the potential additive effect of intraarticular injected Tranexamic Acid (TXA) for the total blood loss in unilateralt total hip arthroplasty in addition to conventional treatment with IV TXA. The intervention group will be given IV TXA at the start of surgery + injection of TXA into the joint (end surgery) VS. TXA at the start of surgery + injection af equal volume of NaCl (placebo).Primary endpoint is total blood loss 24 hours after surgery.
Data and sources
- Registry record
- Listed on the EU's official list of trials (CTIS).
- Official title
- Evaluation of intra articular Tranexamic acid for reduction of total blood loss in total hip arthroplasty
- Record updated
- 11 December 2025